These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 34630912)
21. Role of Mitochondria in Alcoholic Liver Disease. García-Ruiz C; Kaplowitz N; Fernandez-Checa JC Curr Pathobiol Rep; 2013 Sep; 1(3):159-168. PubMed ID: 25343061 [TBL] [Abstract][Full Text] [Related]
22. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318 [TBL] [Abstract][Full Text] [Related]
23. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553 [TBL] [Abstract][Full Text] [Related]
24. Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes. Nagy LE; Ding WX; Cresci G; Saikia P; Shah VH Gastroenterology; 2016 Jun; 150(8):1756-68. PubMed ID: 26919968 [TBL] [Abstract][Full Text] [Related]
26. Pathophysiological Aspects of Alcohol Metabolism in the Liver. Hyun J; Han J; Lee C; Yoon M; Jung Y Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071962 [TBL] [Abstract][Full Text] [Related]
27. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899 [TBL] [Abstract][Full Text] [Related]
33. Gut-liver axis in alcoholic liver disease. Szabo G Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847 [TBL] [Abstract][Full Text] [Related]
34. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. Nagata K; Suzuki H; Sakaguchi S J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478 [TBL] [Abstract][Full Text] [Related]
35. Inflammation in alcohol-associated liver disease progression. Lotersztajn S; Riva A; Wang S; Dooley S; Chokshi S; Gao B Z Gastroenterol; 2022 Jan; 60(1):58-66. PubMed ID: 35042254 [TBL] [Abstract][Full Text] [Related]
37. Role of the endocannabinoid system in alcoholic liver disease. Siegmund SV Dig Dis; 2010; 28(6):751-5. PubMed ID: 21525760 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease. Bukong TN; Iracheta-Vellve A; Saha B; Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Catalano D; Kodys K; Szabo G Hepatology; 2016 Oct; 64(4):1057-71. PubMed ID: 27302565 [TBL] [Abstract][Full Text] [Related]
39. Alcoholic liver disease: focus on prodromal gut health. Park B; Lee HR; Lee YJ J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233 [TBL] [Abstract][Full Text] [Related]
40. Microbiome dysbiosis and alcoholic liver disease Li F; McClain CJ; Feng W Liver Res; 2019 Dec; 3(3-4):218-226. PubMed ID: 33868760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]